Renovis, Inc.
Records under this name other than patents Renovis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,859,545 | Tetrahydronaphthyridine and Tetrahydropyrido[4,3-d]pyrimidine Compounds and Compositions Thereof Useful for the Treatment of Inflammatory and Respiratory Diseases Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,745,451 | TETRAHYDRONAPHTHYRIDINE AND TETRAHYDROPYRIDO[4,3-d]PYRIMIDINE COMPOUNDS AND COMPOSITIONS THEREOF USEFUL IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH NEUROLOGICAL AND INFLAMMATORY DISORDERS AND DYSFUNCTIONS Formerly held In force · High confidence | In force | High confidence | |
| US 8,093,265 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof Formerly held Lapsed on the fee record Ended Jan 10, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 10, 2024 | From the USPTO record |
| US 7,985,553 | Method for Isolating Cell Type-Specific Mrnas Formerly held Lapsed on the fee record Ended Jul 26, 2023 · High confidence | Lapsed on the fee record | Ended Jul 26, 2023 | High confidence |
| US 8,513,485 | Non Human Transgenic Mammal Comprising a Transgene Comprising a Nucleotide Sequence Encoding a Ribosomal Protein Fused to a Peptide Tag Formerly held Term ended Term ended Oct 29, 2022 · High confidence | Term ended | Term ended Oct 29, 2022 | High confidence |
| US 7,816,371 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof Formerly held Lapsed on the fee record Ended Oct 19, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 19, 2022 | From the USPTO record |
| US 8,779,144 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof Formerly held Lapsed on the fee record Ended Jul 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2022 | From the USPTO record |
| US 8,653,091 | Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof Formerly held Lapsed on the fee record Ended Feb 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 18, 2022 | From the USPTO record |
| US 8,546,579 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof Formerly held Lapsed on the fee record Ended Oct 1, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 1, 2021 | From the USPTO record |
| US 8,076,345 | 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof Formerly held Lapsed on the fee record Ended Dec 13, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2019 | From the USPTO record |